Basel, Switzerland

Barbara Biemans

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • Basel, CH (2017 - 2022)
  • Riehen, CH (2021 - 2024)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Barbara Biemans: Innovator in Pharmaceutical Compounds

Introduction

Barbara Biemans is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various medical conditions. With a total of 10 patents to her name, Biemans has established herself as a key figure in innovation.

Latest Patents

Among her latest patents, Biemans has developed ethynyl derivatives, which are compounds that may be utilized in the treatment of Parkinson's disease, anxiety, emesis, obsessive-compulsive disorder, autism, neuroprotection, cancer, depression, or type 2 diabetes. Additionally, she has created arylsulfonamide derivatives, providing new compounds with a general formula that includes compositions, manufacturing processes, and methods of use.

Career Highlights

Throughout her career, Barbara Biemans has worked with notable companies, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her work in these organizations has allowed her to advance her research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Biemans has collaborated with esteemed colleagues such as Georg Jaeschke and Antonio Ricci, further enhancing her research and development efforts in the pharmaceutical industry.

Conclusion

Barbara Biemans is a trailblazer in the field of pharmaceutical innovation, with a focus on developing compounds that address critical health issues. Her contributions continue to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…